Prevalence of major blood group antigens in blood donors at a main donation center in United Arab Emirates by Sajwani, F.H. et al.
IMMUNOHEMATOLOGY, Volume 37, Number 4, 2021 171
Blood transfusion is a common practice in hospitals. In many 
diseases, transfusion of red blood cells can be a life-saving 
measure. Knowing the blood group phenotypes of the donors 
in any population is important to improve health care services 
and to better serve patients. We aimed to determine the blood 
group phenotypes of the regular donors visiting the main blood 
donation center in Sharjah, United Arab Emirates (UAE). A total 
of 500 regular blood donors were included, and blood group 
antigens were tested using serologic methods. Major blood group 
systems included in this testing were ABO, Rh, Kell, Kidd, Duffy, 
Lewis, Lutheran, MNS, and P1PK. The most prevalent ABO/D 
blood type was group O, D+ (29.6%), with the most prevalent 
phenotype in the Rh blood group system reported as R1r (34.4%). 
In the Kell system, the K–k+ phenotype was reported in 92.4 
percent of individuals tested. The rare Duffy null phenotype, 
Fy(a–b–), was reported in 11.0 percent of the cohort. Most 
donors (99.0%) were Lu(b+). In the Lewis system, the phenotype 
Le(a–b+) was seen in 61.8 percent of the donors. MNS system 
phenotypes were comparable to the reports from Saudi Arabia 
and India, with M+N+S–s+ being the most prevalent (21.2%). 
The prevalence of many major blood group phenotypes in the 
UAE blood donor population showed similarities to results 
from populations in neighboring countries, but other phenotype 
prevalences were unique to this population. This finding can 
be used to build a blood group registry for the local population 
that can better serve hospitals’ transfusion requirements. 
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Blood groups are determined by inherited characteristics 
of red blood cell (RBC) membrane antigens.1 These antigens 
can be sugars or proteins, and they are classified by the 
International Society of Blood Transfusion (ISBT) into 
systems, collections, and series.1–3 The blood group systems 
consist of one or more antigens that are produced by one or 
more closely related genes. The ISBT has identified 43 blood 
group systems and more than 300 RBC antigens.4
In the field of transfusion medicine, it is critically 
important to understand the blood group antigens and the 
significance of their associated antibodies. Alloimmunization 
is defined as the production of antibodies against a foreign 
(non-self) antigen when the immune system is exposed to 
a non-self antigen. This exposure can occur during blood 
transfusion, pregnancy, or organ transplantation when there 
is a dissimilarity between the RBC antigens of the donor and 
the recipient.5,6 The development of such alloantibodies can 
affect blood transfusion, leading to known transfusion-related 
side effects7,8 such as delayed hemolytic transfusion reaction,6 
hemolytic disease of the fetus and newborn,9 and delay or 
difficulty in finding compatible RBC units for transfusion 
(especially for regularly transfused patients).2
When a patient develops alloantibodies against RBC 
antigens and requires transfusion, the best management 
option to avoid complications is to transfuse the patient with 
RBCs that are antigen-negative for the clinically significant 
alloantibodies detected. Patients who are regularly transfused 
can develop multiple alloantibodies to RBC antigens that 
they lack. This antibody development can lead to difficulty 
in finding antigen-negative blood for future transfusions. 
In these patients, transfusion with RBC units that are 
phenotypically matched to their own phenotype from the 
first blood transfusion can save time and money as well as 
lower the incidence of alloimmunization. The availability of a 
national database for extended RBC antigen phenotypes can 
help in preventing transfusion-related side effects by providing 
a source to better antigen-match donors to specific recipients. 
This matching is especially useful in regularly transfused 
patients such as patients with thalassemia major. 
The aim of this study was to determine the phenotype 
prevalence in the major blood group systems among regular 
blood donors at the Sharjah Blood Transfusion and Research 
Center in the United Arab Emirates (UAE). The study was 
approved by the research ethics committee in the Ministry of 
Health and Prevention, REC-MOHAP (reference MOHAP/
DXB/JAA/No. 30 2019).
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Materials and Methods
Sample Size and Inclusion Criteria
The study was conducted at the Sharjah Blood Transfusion 
and Research Center, which is the main blood donation center 
in the Ministry of Health and Prevention, UAE. The center 
collects over 27,000 blood units annually, including whole 
blood as well as apheresis blood components.
Based on the total number of regular donors in this study 
(7100 donors in 2020), the sample size was calculated to be 
382 (confidence level of 95%); however, the sample size in this 
study was extended to include 500 blood donors, narrowing 
the confidence interval and providing greater accuracy. All 
regular blood donors visiting the center for blood donation 
and agreeing to participate in the study were included until the 
participant number reached 500. Donors were included only 
once during the study period.
Blood donors included in the study must have donated 
twice or more in the past 3 years (regular donors) as well as 
fulfilled the center’s other donor eligibility criteria. The donors 
gave informed consent before being enrolled.
Sample Collection and RBC Extended Antigen 
Phenotyping
One 3.0-mL EDTA tube was collected from each donor at 
the time of the blood donation, and the sample was processed 
for RBC blood group testing per standard procedure.
For the ABO/D testing, both forward and reverse typings 
were performed using DiaClon ABO/D + Reverse Grouping ID 
cards and ID-DiaCell ABO (Bio-Rad, Cressier, Switzerland). 
A RBC suspension (5%) was prepared by dispensing 50 µL 
of whole blood sample in 0.5 mL ID-Diluent 2 (low-ionic-
strength saline, Bio-Rad). For the reverse typing, the donor 
sample was centrifuged for 5 minutes at 3000–3500 rpm to 
separate the RBCs from the plasma. A total of 50 μL of plasma 
was added to the microtubes in the ID card corresponding to 
A1 and B RBCs.
When the D typing was reported as negative, further 
testing was performed to detect weak D and partial D using an 
ID-DiaClon Anti-D card (Bio-Rad). A DiaClon Rh-Subgroup + 
K card was used to detect C, c, E, e, and K antigens. 
ID-Antigen profile I, II, and III cards were selected from 
Bio-Rad to detect the following antigens (including controls):
Profile I: P1, Lea, Leb, Lua, Lub
Profile II: k, Kpa, Kpb, Jka, Jkb
Profile III: M, N, S, s, Fya, Fyb
Samples were prepared and processed per the 
manufacturer instructions. The cards were run on the 
automated IH-1000 analyzer (Bio-Rad).
Result Reporting
A positive result was reported when the microtube showed 
RBC agglutination. The strength of the agglutination was 
graded from + to ++++. A negative result was reported when 
there was no RBC agglutination, and the RBCs collected at the 
bottom of the microtube.
Statistical Analysis
Prevalence of blood group antigens among the regular 
donor population at Sharjah Blood Transfusion and Research 
Center was calculated and presented as percentages from total 
sample size. The correlation between the blood group antigen 
percentages and donor nationality was determined using the χ2 
test. A p value <0.05 was considered significant. The findings 
from this study were also compared with similar studies in the 
region.
Results
A total of 500 regular blood donors were included in the 
study, and their blood samples were typed for antigens in 
the major blood group systems (ABO, Rh, Kell, Kidd, Duffy, 
Lewis, Lutheran, MNS, and P1PK). A total of 28 nationalities 
were reported. UAE citizens accounted for 26.0 percent (130 
of 500) of the study population (Fig. 1). Nationality was not 
documented for two donors (0.4%).
For ABO/D testing, the most frequent finding was group 
O, D+ (29.6%), followed by group B, D+, group A, D+, group 
O, D–, group AB, D+, group A, D–, and group B, D–. The least 
frequent was group AB, D– (0.8%) (Table 1).
For the Rh system, e tested positive in the majority of 
samples (98.6%) followed by D (86.6%), c (75.6%), C (74.6%), 
and E (22.2%). Weak or partial D was not reported in this 
cohort.
Among D+ donors, the most common phenotype was 
R1r, reported in 172 donors (34.4%), followed by R1R1 and 
R1R2. The phenotypes R0 and R2r had similar distributions 
in the study population, accounting for 5.8 and 5.6 percent, 
respectively. Further analysis of D– donors showed rr to be 
the most prevalent phenotype (92.5% of all D– donors and 
12.4% of all Rh phenotypes). Table 2 shows the prevalence of 
the Rh phenotypes.
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For the Kell system, 100 percent were k+ and Kp(b+). 
The phenotypes K+k– and K–k– were not reported. The 
most prevalent phenotype for the K/k antigens was K–k+, 
accounting for 92.4 percent, and for the Kp antigens was 
Kp(a–b+) (97.2%).
Kidd system testing showed Jk(a+b+) to be the most 
prevalent phenotype (47.6%), followed by Jk(a+b–) at 32.4 
percent.
The prevalence of the common Duffy system antigens 
was 59.4 and 58.8 percent for Fya and Fyb, respectively, 
with Fy(a+b–) accounting for the majority of the phenotypes 
(49.8%).
For the Lewis blood group system antigens, the most 
prevalent phenotype was Le(a–b+), seen in 61.8 percent of 
Fig. 1 Nationality distribution of the study population.
Table 1. Distribution of ABO/D antigens in regular blood donors in 
the United Arab Emirates 
Blood group, D type Current study, % (n)
O, D+ 29.6 (148)
O, D– 5.4 (27)
A, D+ 23.4 (117)
A, D– 4.6 (23)
B, D+ 28.4 (142)
B, D– 2.6 (13)
AB, D+ 5.2 (26)
AB, D– 0.8 (4)
Table 2. Rh phenotype prevalence in the United Arab Emirates 
population compared with other populations
Phenotype Current study Oman KSA Iran* India 
DCe 24.4 22.8 14 22.4 39.5
DCcEe 15.0 18.3 9.0 14.6 11.2
Dce 5.8 5.7 9.0 1.8 2.2
DcE 1.4 1.5 3.0 2.3 0.7
DcEe 5.6 8.1 9.0 10.4 5.7
DCce 34.4 32.6 39.0 27.7 34.4
ce 12.4 10.5 20.0 9.59 5.9
cEe 0.2 0.0 — 0.45 —
Cce 0.8 0.3 — 1.95 0.3
* The study in Iran presented the prevalence of D+ phenotypes among the 
D+ subgroup and D– phenotypes in the D– subgroup.7
KSA = Kingdom of Saudi Arabia.
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Table 3. Blood group phenotype frequencies in the United Arab Emirates population compared with other populations
Blood group system Phenotype Current study Oman KSA* Iran† India‡
ABO/D
O, D+ 29.6 44.9 42.0 33.1 24.3
O, D– 5.4 7.4 5.5 3.7 1.9
A, D+ 23.4 17.4 23.4 29.2 28.4
A, D– 4.6 0.6 2.8 3.1 1.96
B, D+ 28.4 20.2 20.9 21.4 29.8
B, D– 2.6 2.7 2.1 2.2 1.9
AB, D+ 5.2 6.8 3.4 7.1 11.0
AB, D– 0.8 — 0.5 0.6 0.66
Kell system
K+k+ 7.6 4.5 8.0 4.8 1.97
K+k– 0.0 0.0 0.0 0.2 0.0
K–k+ 92.4 94.9 92.0 95 98.0
K–k– 0.0 0.6 0.0 — 0.0
Kp(a+b+) 2.8 2.7 — 0.8 —
Kp(a+b–) 0.0 0.0 — Rare —
Kp(a–b+) 97.2 97.3 — 99.0 —
Kp(a–b–) 0.0 — — — —
Kidd system
Jk(a+b+) 47.6 47.0 46.0 49.0 46.1
Jk(a+b–) 32.4 35.4 40.0 29.0 30.7
Jk(a–b+) 19.8 17.3 14.0 22.0 22.8
Jk(a–b–) 0.2 0.3 0.0 Rare 0.39
Duffy system
Fy(a+b+) 29.0 7.4 5.0 43.0 48.3
Fy(a+b–) 49.8 9.2 17.0 29.0 36.2
Fy(a–b+) 10.2 14.9 17.0 28.0 15.4
Fy(a–b–) 11.0 68.5 61.0 3.4 0.39
Lewis system
Le(a+b+) 0.8 0.3 3.0 7.9 0.0
Le(a+b–) 24.0 21.4 29.0 — 16.1
Le(a–b+) 61.8 67.0 49.0 — 24.8
Le(a–b–) 13.4 11.3 19.0 — 59.1
Lutheran system
Lu(a+b+) 1.8 2.4 2.0 6.0 0.39
Lu(a+b–) 0.4 0.6 0.0 3.0 0.0
Lu(a–b+) 97.2 94.3 97.0 91.0 99.6
Lu(a–b–) 0.6 2.7 1.0 0.0 0.0
MNS system
M+N–S+s– 9.6 – 11.0 – 7.1
M+N–S+s+ 18.8 22.6 24.0 — 14.96
M+N–S–s+ 12.8 — 13.0 — 13.8
M+N+S+s+ 18.4 — 15.0 — 20.9
M+N+S–s+ 21.2 — 21.0 — 28.7
M+N+S+s– 5.8 — 3.0 — 5.1
M–N+S+s+ 4.4 — 3.0 — 3.15
M–N+S+s– 0.8 — 3.0 — 1.2
M–N+S–s+ 8.0 — 7.0 — 5.1
M–N–S+s+ 0.2 — — — —
P1PK system
P1+ 75.0 78.9 85.0 67.0 60.6
P1– 25.0 21.1 15.0 33.0 39.4
Based on the data available from the published literature: 
* Data for ABO prevalence in blood donors in Kingdom of Saudi Arabia (KSA) are from Alabdulmonema et al.,12 and the data for the other major group systems 
are from Owaidah et al.17
† Data for the Duffy system are from Keramati et al.,14 and the data for other major blood group systems are for the Iran general population from Shahverdi et al.7
‡Data for ABO prevalence in blood donors in India are from Kumar et al.,16 and the data for the other major group systems are from Agarwal et al.3
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donors. A similar pattern was reported for the Lutheran blood 
group system; 99.0 percent of the donors were Lu(b+) and only 
2.2 percent were Lu(a+), making Lu(a–b+) the most common 
phenotype (Table 3). 
For the MNS blood group system, M+N+S–s+ was the 
most frequently observed phenotype, with a prevalence of 
21.2 percent. For the P1 antigen, 75.0 percent of the blood 
donors were P1+.
When analyzing these blood group systems among only 
UAE nationals (130 blood donors), similar findings were 
reported for the ABO and D results, with group O, D+ being 
the most prevalent (41.5% in UAE nationals) followed by group 
B, D+, group A, D+, and group O, D–. Blood group A, D– was 
more common than group AB, D+, with group B, D– being the 
least prevalent. The blood group AB, D– was not reported in 
UAE nationals in this study population.
For the other major blood group systems, the same 
distribution trend was seen in UAE nationals as reported 
in the general donor population. The Duffy system was an 
exception: in the general population, the Fy(a+b–) phenotype 
was reported as the most prevalent (49.8%), whereas in UAE 
nationals, Fy(a–b+) was the most prevalent [30.0% compared 
with 28.5% for Fy(a+b–)]. Table 4 shows the prevalence of the 
phenotypes in the general blood donor population compared 
with donors who are UAE nationals.
Analysis of the occurrence of the major blood group anti-
gens as influenced by the nationality of the donor was attempted. 
We found that C, P1, Fya, Fyb, and Lua showed statistically 
significant distribution in relation to the nationalities, with p 
values of 0.01, 0.03, 0.00, 0.001, and 0.025, respectively.
Discussion
In this study, we aimed at determining the prevalence of 
major blood group system phenotypes among regular blood 
donors in UAE. This information can support the health 
care system by providing the best RBC match for patients, 
especially those who are regularly transfused because of their 
disease pathology with the aim of minimizing side effects 
related to alloimmunization.
To our knowledge, there has been one published Master’s 
thesis10 conducted on UAE nationals in the city of Al-Ain to 
determine the prevalence of major blood group phenotypes.
When compared with other studies published in 
neighboring Middle Eastern countries, similar trends were 
observed. As reported in the Omani population and the central 
region of the Kingdom of Saudi Arabia (KSA), group O, D+ was 
the most prevalent ABO group and D type (as in our study), 
followed by group B, D+ and group A, D+.11,12 In Bahrain and 
Iran, group O, D+ was also most prevalent,7,13–15 whereas in 
the Indian population, group B, D+ was more prevalent.3,16
For the Kell system, studies published in Oman, KSA, Iran, 
and India showed K–k+ to be the most reported phenotype, 
and the same was seen in the current study in UAE.3,7,11,17 
In UAE blood donors, the Kp(a–b+) phenotype was seen in 
97.2 percent of the donors, and Oman also reported the same 
phenotype in 97.3 percent of their blood donors. In India, a 
higher percentage was reported (99%), making this phenotype 
the most common in the region.
Duffy system distribution in UAE donors was found to 
be different from that reported in other countries. The rare 
phenotype Fy(a–b–) was reported in 11.0 percent in our 
study, compared with 3.4 percent in Iran14 and 0.39 percent in 
India,3 whereas other countries in the region reported higher 
prevalence of this phenotype (Oman: 68.5%; eastern region of 
KSA: 61.0%), which is similar to the prevalence seen in the 
African population.
In this study, 28 different nationalities were reported, 
reflecting the diversity in the UAE population. A further look 
into the distribution of Duffy system phenotypes only in UAE 
nationals from the study sample showed that the prevalence 
reported in UAE nationals differ from that reported in the 
general donor population in UAE for this specific blood group 
system.
Comparing the prevalence of Kidd, Lewis, and Lutheran 
system phenotypes in UAE blood donors with the data 
available from other countries in the region showed that blood 
donors in UAE have a similar distribution of the various 
phenotypes in those systems, as shown in Table 3.
The prevalence of the M+N+S–s+ phenotype in blood 
donors from the eastern region of KSA and India as well 
as in the current study was similar, whereas in the Omani 
population, the phenotype M+N–S+s+ was mostly seen.11,17
Table 4. Duffy system phenotype distribution in UAE nationals 
compared with total study population





UAE = United Arab Emirates.
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For the Rh system, R1r was the most frequently reported 
phenotype among D+ donors in the current study as well as in 
Omani, KSA, and Iranian populations, whereas in India, R1R1 
was seen in the majority. Comparison of their prevalence is 
shown in Table 2.18
Looking into the D– group, the phenotype rr was the most 
frequently reported in all the reviewed studies.
One of the reasons for our study sample having similar 
major blood group system phenotype distributions as other 
Gulf countries is attributed to similar ancestry in the Arabian 
Peninsula. Similarities to a lesser extent with Iranian and 
Indian populations can be explained by the long history of 
trading between UAE and these countries, with possible 
marriages between individuals of these nationalities and UAE 
nationals.
This study described the distribution of different blood 
group system phenotypes among regular blood donors in 
UAE. Compared with the data available from published 
literature in the region, similarities were reported in some 
blood group systems, and differences were observed in others, 
such as the Duffy blood group system; this finding points to 
the uniqueness of each population.
This study included blood donors from Sharjah Emirate 
at one of the reference donation centers in UAE; there are 
more national blood donation centers covering the donation 
service in other emirates across the country. Collecting data 
from these blood donation centers can add value to the current 
study. In addition, a larger-scale study is needed to confirm the 
correlation of antigen occurrence with nationality.
There are limited data on the distribution and prevalence 
of major blood group phenotypes in the region, and further 
studies examining the distribution of these blood group 
system phenotypes to build a national database for blood 
donor phenotypes can help in better serving blood transfusion 
patients across the country.
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